Showing results (901-910 of 2,709) with videos related to
Sort By:
Pageof 271
Fundamental & Clinical Pharmacology|June 4, 2011
St John's wort greatly decreases the plasma concentrations of oral S-ketamineMarko A Peltoniemi, Teijo I Saari, Nora M Hagelberg, et al.Fundamental & Clinical Pharmacology|April 28, 2011
Na(+)/K(+)-ATPase inhibition upregulates NMDA-evoked currents in rat hippocampal CA1 pyramidal neuronsLinan Zhang, Fang Guo, Suwen Su, et al.Fundamental & Clinical Pharmacology|March 12, 2011
The peroxisome proliferator-activated receptor α agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lungJulien Becker, Carine Delayre-Orthez, Nelly Frossard, et al.Fundamental & Clinical Pharmacology|March 1, 2011
Puerarin protects human umbilical vein endothelial cells against high glucose-induced apoptosis by upregulating heme oxygenase-1 and inhibiting calpain activationYing-Ying Chen, Jie Chen, Xin-Mei Zhou, et al.Fundamental & Clinical Pharmacology|March 1, 2011
Furosemide-induced genotoxicity and cytotoxicity in the hepatocytes, but weak genotoxicity in the bone marrow cells of miceSambhu Charan Mondal, Durga Nand Tripathi, Ajit Vikram, et al.Fundamental & Clinical Pharmacology|January 12, 2011
Use of intravenous immunoglobulins in clinical practice: data from three French university hospitalsElisabeth Frauger, Jerome Grassi, Vincent Pradel, et al.Fundamental & Clinical Pharmacology|January 19, 2011
Antiplatelet drugs in the elderly: prescriptions often inappropriate and reduced tolerance by associated diseases and drugsGwénaëlle Cadiou, Magali Adam, Marie Caussin, et al.Fundamental & Clinical Pharmacology|January 1, 1990
With whom does the French drug industry want to work for phase I?Y BogaievskyFundamental & Clinical Pharmacology|January 1, 1990
Predictive value of phase I studies: relevant criteriaJ Sassard, N Pozet, N Bernard, et al.Pageof 271